Cytogenetic Harvesting of Cancer Cells and Cell Lines.

Methods Mol Biol

Department of Human and Animal Cell Lines, German Collection of Microorganisms and Cell Cultures, Leibniz Institute-DSMZ, Inhoffenstr. 7b, 38124, Braunschweig, Germany.

Published: January 2018

We describe an evidence-based approach toward optimizing chromosome preparation from cancer cells and cell lines. The procedures described here emphasize the utility of both cell culture-to maximize the yields of the dividing cells needed to harvest mitotic metaphase chromosome preparations and how an empirical evaluation of hypotonic treatments enables optimal conditions to be efficiently determined.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6703-2_5DOI Listing

Publication Analysis

Top Keywords

cancer cells
8
cells cell
8
cell lines
8
cytogenetic harvesting
4
harvesting cancer
4
lines describe
4
describe evidence-based
4
evidence-based approach
4
approach optimizing
4
optimizing chromosome
4

Similar Publications

In this study, we synthesized 12 monofunctional tridentate ONS-donor salicylaldimine ligand ()-based Ru(II) complexes with general formula [(Ru()(-cymene)]·Cl (-), characterized by H NMR, C NMR, UV, FT-IR spectroscopy, HR-ESI mass spectrometry, and single-crystal X-ray analysis showing ligand's orientation around the Ru(II) center. All 12 of these 12 complexes were tested for their anticancer activities in multiple cancer cells. The superior antitumor efficacy of , , and was demonstrated by reduced mitochondrial membrane potential, impaired proliferative capacity, and disrupted redox homeostasis, along with enhanced apoptosis through caspase-3 activation and downregulation of Bcl-2 expression.

View Article and Find Full Text PDF

Objective: Endometrial cancer (EC) is a malignant tumor with various histological subtypes and molecular phenotypes. The evaluation of drug resistance is important for cancer treatment. Progesterone resistance is the major challenge in EC.

View Article and Find Full Text PDF

The P2YR is activated by UDP and UDP glucose and is involved in many human inflammatory diseases. Based on the molecular docking analysis of currently reported P2YR antagonists and the crystallographic overlap study between PPTN and compound , a series of 3-substituted 5-amidobenzoate derivatives were designed, synthesized, and identified as promising P2YR antagonists. The optimal compound (methyl 3-(1-benzo[]imidazol-2-yl)-5-(2-(-tolyl) acetamido)benzoate, IC = 0.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common malignant primary brain tumor, with a mean survival of less than 2 years. Unique brain structures and the microenvironment, including blood-brain barriers, put great challenges on clinical drug development. Sophoricoside (Sop), an isoflavone glycoside isolated from seeds of Sophora japonica L.

View Article and Find Full Text PDF

Mechanistic understanding of pH as a driving force in cancer therapeutics.

J Mater Chem B

January 2025

Department of Forensic Science, School for Bio Engineering and Bio Sciences, Lovely Professional University, Phagwara, Punjab, India.

The development of pH-directed nanoparticles for tumor targeting represents a significant advancement in cancer biology and therapeutic strategies. These innovative materials have the ability to interact with the unique acidic microenvironment of tumors. They enhance drug delivery, increase therapeutic efficacy, and reduce systemic toxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!